This study is an observational, cohort, prospective study looking at the frequency of Herpes Simplex Virus (HSV) 1 and or 2 outbreaks in HIV positive patients who's HIV virus is controlled on highly active anti-retroviral therapy. We will be enrolling fifty (50) patients.
We will be confirming that the patients are HIV positive and has antibodies to either HSV 1 or HSV 2 as part of the screening process. If so, we will then obtain patient baseline HIV-PCR, CD4, medial history including medications on day one. Whether the patient is on any or no herpes controlling medication. If the patient has what they feel is a flare up of HSV, they will come into clinic where the lesion will be culture and the patient's HIV-PCR and CD4 will also be obtained. Otherwise, the patient will receive phone follow ups every three months to see if there has been and change in their health or medications. The main endpoint is to see if there is a correlation between outbreaks in HIV patients and their CD4 cells and/or HIV and/or Herpes medication.
Study Type
OBSERVATIONAL
Enrollment
50
We will be drawing blood for verify HIV status, HSV 1 or 2 antibodies, CD4 and HIV-PCR
Global Research Institute
Los Angeles, California, United States
RECRUITINGEpidemiology
The frequency of HSV outbreaks in HIV positive patients.
Time frame: 48 weeks
Co Morbidity
Correlation of HSV outbreak with patient CD4 count and/or HIV-PCR
Time frame: 48 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.